Lumactod, Rafica .

HRN: 24-77-03  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/27/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/27/2024
04/03/2024
IV
500mg
Q8
Am
Waiting Final Action 
03/29/2024
CEFTRIAXONE 1G (VIAL)
03/29/2024
04/04/2024
IV
2 Gms
OD
UTI
Waiting Final Action 
04/02/2024
METRONIDAZOLE 500MG (TAB)
04/02/2024
04/08/2024
ORAL
500 Mg
Q8
.
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: